October 15, 2026 - EverGlade

October 15, 2026

NSF X-Labs Funding Targets Bioengineering: From Protein Sequence to Function

The National Science Foundation (NSF) has announced From Sequence to Function, a new NSF X-Labs topic supporting platform technologies that connect protein sequence and structure to predictable, controllable biological function. Written proposals are due February 8, 2027, at 5:00 PM Eastern. NSF anticipates one or more Other Transaction (OT) awards under the topic. Issued through

NSF X-Labs Funding Targets Bioengineering: From Protein Sequence to Function Read More »

NIAID Releases 2027 Omnibus BAA for Vaccines, Therapeutics, and Diagnostics

The National Institute of Allergy and Infectious Diseases (NIAID) has released its 2027 Division of Microbiology and Infectious Diseases (DMID) Omnibus Broad Agency Announcement (BAA) to advance medical interventions for infectious diseases. The solicitation covers three research areas: needle-free vaccines, therapeutic candidates, and in vitro diagnostic platforms. Full proposals for all three areas must be

NIAID Releases 2027 Omnibus BAA for Vaccines, Therapeutics, and Diagnostics Read More »

Scroll to Top